INS and obesity due to melanocortin 4 receptor deficiency: Their potent effects on improving glucose disposal, insulin sensitivity, plasma lipid parameters, and on inducing body weight loss are very similar between these two endocrine FGFs and have been reported in multiple models of diabetes and obesity in rodents and non-human primates.